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59Comparisons between MSC-like populationsmultipotency. Of the two solid organ-specific CFU-F, only kCFU-F displayed suppression of T-cell alloreactivity in vitro, albeit to a
lesser extent than bmMSC. Quantitative immunophenotyping using 81 phycoerythrin-conjugated CD antibodies demonstrated that
all populations contained high percentages of cells expressing diagnostic MSC surface markers (Sca1, CD90.2, CD29, CD44), as well
as others noted previously on murine MSC (CD24, CD49e, CD51, CD80, CD81, CD105). Illumina microarray expression profiling and
bioinformatic analysis indicated a correlation of gene expression of 0.88–0.92 between pairwise comparisons. All populations
expressed approximately 66% of genes in the pluripotency network (Plurinet), presumably reflecting their stem-like character.
Furthermore, all populations expressed genes involved in immunomodulation, homing and tissue repair, suggesting these as
conserved functions for MSC-like cells in solid organs. Despite this molecular congruence, strong biases in gene and protein
expression and pathway activity were seen, suggesting organ-specific functions. Hence, tissue-derived MSC may also retain unique
properties potentially rendering them more appropriate as cellular therapeutic agents for their organ of origin.
Crown Copyright © 2011 Published by Elsevier B.V. All rights reserved.Introduction
Mesenchymal stem cells or multipotent mesenchymal stromal
cells (both referred to as MSC) (Horwitz et al., 2005) are
stem-like cells, traditionally of bone marrow origin, able to
differentiate into a variety of mesenchymal lineages, including
bone, fat and cartilage (Pittenger et al., 1999). Originally
designated Colony Forming Unit-Fibroblast (CFU-F) cells
based upon their phenotype in culture (Friedenstein et al.,
1974; Bianco et al., 2008), attempts to identify, localise and
purify MSC have been hampered by a lack of unique cell surface
marker/s. Currently, the minimal criteria for human MSC
are i) adherence to plastic with fibroblast-like morphology;
ii) expression of CD105, CD73, CD90 and lack of expression
of CD45, CD34, CD14 or CD11b, CD79a/CD19, HLA-DR; and
iii) ability to differentiate into osteoblasts, adipocytes and
chondrocytes in vitro (Dominici et al., 2006; Kassem et al.,
2004). In the mouse, MSC are Sca1+CD90+CD45− (da Silva
Meirelles and Nardi, 2003). Whilst first described in the stroma
of bone marrow, CFU-F have now been reported to exist in
many foetal and adult tissues, including fat, bone, kidney,
lung, liver, umbilical cord, amniotic fluid and placenta (Wang
et al., 2009; Ebihara et al., 2006; Fraser et al., 2007; Steigman
and Fauza, 2007; Sarugaser et al., 2005). As proposed for bone
marrow-derived MSC (bmMSC), such cells may act as tissue
stem cells, provide a niche for other stem cells, or play a role
in tissue homeostasis and repair. Recently, Crisan et al. (Crisan
et al., 2008) prospectively isolated perivascular cells from a
variety of human organs, including kidney, based on the
expression of pericyte markers CD146, NG2 and PDGFRβ
(CD140b), and showed that these cells displayed MSC features.
Other studies also support the concept that MSCs arise from a
perivascular niche (da Silva Meirelles et al., 2006).
Despite similarities between bmMSC and MSC-like popula-
tions from other locations, absolute phenotypic and functional
equivalence has not been established. Indeed, evidence exists
that there is a differentiative and reparative bias that depends
upon the tissue of origin. Both foetal and bmMSC can induce re-
pair after acute necrotizing injury of the heart, but via different
mechanisms (Iop et al., 2008). Placental and foetal MSC from
amniotic fluid express pluripotency genes (Nanog, SSEA-4 and
Oct4), proliferate faster and show greater colony forming effi-
ciency and osteogenic capacity (Roubelakis et al., 2007; Guillot
et al., 2007). This suggests a more primitive stem-like pheno-
type and potentially enhanced utility in bone engineering appli-
cations (Zhang et al., 2009; Guillot et al., 2008). Placental MSC
also show superior migratory capacity but less adipogenicpotential (Li et al., 2009; Montesinos et al., 2009; Barlow et
al., 2008). Adipose MSC show greater capacity to form fat
(Noel et al., 2008), whilst umbilical cord MSC show no such
capacity (Kern et al., 2006). Comparisons of gene expression
between adipose, umbilical cord and bmMSC versus mature
fibroblasts defined 25 genes uniformly present in these MSC
(Wagner et al., 2005; Phinney et al., 2006), but considerable
differences in MSC phenotype and functional capacity were
noted depending upon their tissue of origin (Noel et al., 2008;
Wagner et al., 2005). A microarray comparison between
amniotic fluid, amniotic membrane and cord blood derived-
MSC also suggested specific biological functions for MSC from
different gestational tissues (Tsai et al., 2007).
In this study we compare, both at the transcript and
protein levels, distinct murine organ-specific MSC-like
populations isolated from adult tissues (bone/bone marrow,
heart and kidney). Although initial isolation approaches
varied, once established as plastic adherent cultures dis-
playing the anticipated cell surface antigens to define
them as MSCs (Sca1+CD29+CD44+CD90.2+) all populations
were cultured under identical conditions for a similar pas-
sage number prior to extensive phenotypic and functional
characterisation. We report a high level of concordance
with respect to morphology, growth properties, cell surface
proteins, gene expression profile and multipotentiality in
vitro between these three populations. Our data support a
common phenotype for distinct organ-specific MSCs,
reinforcing the hypothesis that such cells are involved in tis-
sue maintenance and repair (da Silva Meirelles et al., 2008).
However, we also report variations in the level of epitope
presentation and distinct phenotypic signatures, supporting
the concept of molecular ‘memory of tissue origin’ and the
existence of distinct functional roles for MSC-like cells iso-
lated from different tissues.Results
The colony forming assay represents an accepted and robust se-
lection for a specific stem cell-like population (Bianco et al.,
2008; Friedenstein et al., 1974). CFU-F cultures are known to
contain stem cells that are self-renewing but also able to give
rise to more committed progenitors through asymmetric divi-
sion. They may also contain a few differentiated offspring
with time. Whilst the ultimate cultures are not homogeneous,
short term proliferating cells are purged from the cultures by
continued passage. In order to directly compare MSC-like cells
60 R.A. Pelekanos et al.from a variety of tissue sources, we initially derived colony
forming unit-fibroblast (CFU-F) populations from total adult
murine bone marrow, heart and kidney as described in Supple-
mentary data. All cells analysed in this comparative study
were plated inαMEM+20% FCS and subsequently cultured as ad-
herent cells for a similar number of passages prior to further
characterization and functional analysis (Figure 1A). An initial
immunophenotyping for cell surface epitopes considered char-
acteristic of MSCs suggested that all cultures displayed a
Sca1+CD29+CD44+ and CD11b−CD31−CD45−CD117− phenotype,
verifying the MSC nature of all three populations (Supplementa-
ry Figure S1).Comparative phenotype and comprehensive
immunophenotypic analysisAll three populations were plastic-adherent and displayed
similar fibroblast-like morphologies (Figure 1Ba–c). Cells
from all populations had a similar appearance with each
population showing heterogeneity of cell size, large often
peripherally-located nuclei with dense chromatin and a
large amount of granular cytoplasm (Figure 1Bd–f). Cells
varied in size from 20 to 120 μm. Murine bmMSC, cCFU-F
and kCFU-F were all able to differentiate along mesodermal
lineages in vitro when cultured under adipogenic,
osteogenic or chondrogenic conditions (Figure 1Bg–o) al-
though cCFU-F showed less robust formation of chondrocyte
pellets and were slower to induce adipocyte differentiation.The immunophenotype of all three populations was
comprehensively compared using a panel of 81 PE-conjugated
antibodies (Supplementary Table 1). A heat map showed
extensive congruence in the percentage of cells positive for a
given CD epitope between the three populations, although hier-
archical clustering revealed that bmMSC and kCFU-F were more
similar to each other than to cCFU-F (Figure 2A). An examina-
tion of all epitopes detected on >20% of cells in at least one of
the three populations (Figure 2B) highlighted a number of ma-
trix and adhesion molecules, potentially reflecting niche mole-
cules expressed in common. These included CD29, CD44,
CD49e, CD51, CD61, CD81 and CD24. CD105 (endoglin), a mark-
er of primitive haematopoietic stem cells (HSCs), was also
expressed on a high proportion of all cells. The expression of
CD markers associated with immune regulation, including
CD24, CD80, CD81 and CD90.2, implies a common immune reg-
ulatory function for MSC in multiple organs. CD49e, CD51,
CD71 and CD105 have been previously reported on human
MSC (da Silva Meirelles et al., 2008). CD73, generally accepted
as a diagnostic human MSC marker, (Horwitz et al., 2005;
Dominici et al., 2006), was not present on a significant
percentage of any murine population analysed in this study
(Supplementary Table 2). Conversely, CD80, negative on
human MSC, was found on all 3 populations of murine MSC.Figure 1 Experimental plan and analysis of subsequent morpholog
heart and kidney. A. Experimental flow chart indicating the initial i
form passaging prior to comparative characterisation. B. Analysis of
sage. a–c) Light microscopy of adherent cultures. d–f) Light micro
staining of lipid droplets after 21 day culture in adipogenic media.
in osteogenic media. m–o) Alcian blue staining of proteoglycans af
C, 50 μM; D–F, 100 μM, G–H, 50 μM, J–L, 200 μm; M–O, 500 μM.Of note, whilst cCFU-F were isolated as GFP+ cells from a
PDGFRα-GFP mouse strain, the mean percentage of cCFU-F
cells positive for CD140a (detects PDGFRα) was 12%,
comparable to the levels seen in both other populations. Anal-
ysis of the GFP positivity on FITC channel during
immunophenotyping showed 23.7% GFP+ cells. This variation
from the antibody may result from perdurance of the GFP
(Data not shown).Gene expression profiling reveals considerable
congruence between the three populations
To further compare phenotypes, Illumina microarray
expression profiling was performed on RNA isolated from the
three populations. Analysis of expression of >45,000 transcripts
showed that 81.1% of genes were expressed to some degree
across the combined set of samples. Pearson correlations of
pair-wise comparisons revealed r2 values ranging from 0.878
to 0.924 (Figure 3A). This represents a very high level of
similarity between the three cell types, although bmMSC
were again more similar to kCFU-F than to cCFU-F. We ranked
all genes in order of level of expression for all three
populations. Ninety-five of the top 100 bmMSC-expressed
genes were also ranked within the top 250-ranked genes listed
for the other populations (Supplementary Table 4). As
expected, most of the top 100 genes encoded house-keeping
proteins. However, this list also included regulatory molecules
and secreted proteins involved in tissue remodelling, repair
and inflammatory modulation. Amongst the most highly
expressed genes in all lines was Zyxin, Thymosin β10 and
Macrophage inhibitory factor (MIF) (Supplementary Table 4).
Zyxin (ranked 1 for cCFU-F, 10 for kCFU-F and 35 for bmMSC)
encodes a member of the LIM domain family of focal adhesion
adaptor proteins that is likely to also serve as a component of
transcription factor complexes. Thymosin β10, a monomeric
actin-sequestering protein, is secreted and has paracrine
functions in wound repair (Huang et al., 2006), vasculogenesis
(Lee et al., 2005), inflammation and cancer (Lapteva et al.,
2001; Califano et al., 1998). In contrast to its paralogue
thymosin β4, which is pro-angiogenic, thymosin β10 inhibits
angiogenesis. MIF protein has emerged as a major
inflammatory mediator through its chemokine-like functions,
acting both upstream and downstream of inflammatory
inducers. It has been proposed as a “master regulator” for
leukocyte chemotaxis and arrest. MIF is also pro-angiogenic
and inhibits migration and division of smooth muscle (SM)
cells. Other commonly expressed secreted products included
biglycan, a proteoglycan that modulates cellular proliferation
and migration; serpinh1/HSP47, a procollagen chaperone
involved in collagen remodelling and formation of scar tissue;
serpinf1/PEDF, an inhibitor of endothelial cell proliferation and
migration whilst also acting as a fibroblast chemoattractant;y and multipotency of tissue-specific MSC-like populations from
solation of subfractions able to generate CFU-F followed by uni-
the differentiative capacity of the three populations after pas-
scopy of Giemsa-stained cytospin preparations. g–i) Oil red-O
j–l) Alizarin red staining of osteoid matrix after 21 day culture
ter 21 day pellet culture in chondrogenic media. Scale bars: A–
61Comparisons between MSC-like populationsSparc/Osteonectin, an MMP-activated, collagen-binding protein
implicated in collagen fibril and basal lamina formation; and
CTGF/CCN2, a known mediator of tissue fibrosis. These allstrongly reflect the fibroblastic phenotype of these cells.
Pathway analysis of genes expressed in common between these
MSC populations identified genes involved in immunity, cell
62 R.A. Pelekanos et al.adhesion, BMP signalling, chemokine signalling, homeodomain
transcription factors, metalloproteinases and their TIMP
inhibitors (Table 1).Microarray data was validated using quantitative PCR
(qPCR). This was first performed on a set of genes chosen for
their wide variation in gene expression between the three cell
types (Prl2c2, GHR, Zyx, Des) (Supplementary Figure S2).
qPCR was then performed to validate the expression of genes
regarded as classical MSC (Wagner et al., 2005; Phinney et al.,
2006) and/or pericyte markers (da Silva Meirelles et al., 2008;
Covas et al., 2008) (Twist1, CCL7, MMP2, MIF, HoxA5, Tagln)
(Muller et al., 2008) (Supplementary Figure S3). This
demonstrated good validation of relative expression levels
between microarray and qPCR.
Enrichment for stem cell networks in all three
MSC-like populations
To investigate the stem cell nature of these three populations,
the expression of murine orthologs of components of the re-
cently described Plurinet was examined in these cell lines
(Muller et al., 2008). Murine orthologs of the human Plurinet
genes were examined for their mean normalised
expression and 66% of these orthologs displayed an Illumina de-
tection score >0 in at least one population (Supplementary
Table 6). In addition, hierarchical clustering showed strong
congruence between the three CFU-F populations
(Figure 3B). Once again, a closer relationship was evident be-
tween bmCFU-F and kCFU-F. Figure 3C illustrates the subcellu-
lar localisation and network relationships of those Plurinet
genes expressed by these populations and qPCR was used to
validated these results for a subset of Plurinet genes detected
as present in the three populations (Myc, AnxA2 and Smarcad1)
(Supplementary Figure S4). We also investigated the expres-
sion of genes critical for induced pluripotency. Expression of
Klf4 and Sox2 (not in the Plurinet), whilst above the threshold
for detection by microarray, was very low (Supplementary Fig-
ure S4). Expression of both Nanog and Oct4 (Pou5f1) fell below
the Illumina detection threshold for all cell lines. qPCR for
these genes also indicated extremely low levels of mRNA
(Supplementary Figure S4). Despite this, the extensive
expression of other Plurinet genes implies an active stem cell
state in all three MSC-like populations.
Immunosuppressive capacity of bmMSC, cCFU-F
and kCFU-F
bmMSC have long been known to be immunomodulatory,
affecting the proliferation and phenotype of T-cells, B-
cells, NK cells and antigen-presenting cells through a cyto-
kine/chemokine cascade (Kode et al., 2009). Lacking MHC
Class II, they are also immunoprivileged in an allogeneic set-
ting, leading to the concept of an “off-the-shelf” therapy for
regenerative medicine. Given the molecular and immuno-
phenotypic evidence for considerable congruence between
these three populations, we assessed the in vitro capacity
of each population to suppress T-cell proliferation when
added to a mixed lymphocyte reaction using LPS-
stimulated allogeneic T-cells as responders (Figure 4A).
bmMSC were suppressive at both low and high numbers ofcells added (MSC:responder ratios 1:100 and 1:10,
respectively). kCFU-F were only significantly suppressive
using the higher number of cells. In contrast, cCFU-F were
not suppressive with either cell number. This was confirmed
in a “third party” MLR in which cCFU-F, donor and responder
lymphocytes were all mismatched for MHC. In this setting,
cCFU-F in fact increased responder T-cell proliferation
(data not shown), suggesting a possible pro-survival effect
(Xu et al., 2008).
Correlating differences in gene expression with
functional behaviour
Given this functional difference between the populations,
hierarchical clustering was performed on a set of 6487
genes shown to be differentially expressed between the 3
populations (Figure 4B). The number of genes differentially
expressed (B>0, pb0.005) between bmMSC and kCFU-F
was 2746, with 3535 between cCFU-F and kCFU-F and 4572
between bmMSC and cCFU-F (Figure 4C). We then identified
genes in which expression was differentially higher or lower
in one of the three populations versus the remaining two
(Figures 4D,E). Genes up-regulated in one population
represent genes enriched in or specific to a given cell type
(Figure 4D). These genes are listed in Supplementary Table
7A, C and E. We have defined specific markers of each
cell population as those genes for which expression in the
population of interest was >500RFU, expression in the com-
parative populations was b200RFU and the fold difference
greater than 5. Table 2 lists the 5 most population-specific
genes. Genes that were differentially under-expressed in a
given cell type were also identified (Figure 4E, Supplementary
Table 7B, D, F). Genes underexpressed in bmMSC represent
genes commonly enriched in the two solid tissue-derived
MSC populations.
Organ-specific gene expression signatures in
MSC-like populations
Observed differences in gene expression between these
three populations should inform our understanding of func-
tions enhanced in one organ but reduced in others,
unique organ-specific functions, and potentially features
that relate to the cellular or developmental origins of
organ-specific CFU-F (“memory of tissue origin”). In
the case of kCFU-F, the enriched expression of Mylk,
Myom, Desmin and Serpinb2 (Supplementary Table 7C) sug-
gests a strong relationship with the perivascular and mesan-
gial cells of the kidney, in keeping with the proposed
perivascular origin for MSC (Bianco et al., 2008; Crisan et
al., 2008). As well as mesangial cells, Mylk and Myom1 are
expressed in smooth muscle, as is Myh11, a gene expressed
equivalently in cCFU-F and kCFU-F but not in bmMSC. This
may again reflect a perivascular location due to the more
established arterio-venous circulation present in solid or-
gans. No evidence was found for the derivation of kCFU-F
from the nephron epithelia. kCFU-F also differentially ex-
press Nestin. This gene is expressed in a number of stem
cell populations and has been proposed as a marker of
multipotent progenitors (Wiese et al., 2004). Nestin
Figure 2 Comprehensive CD epitope profiling of bmMSC, cCFU-F and kCFU-F populations. A) Clustered heat map representation of
data from (total number) cell surface antigens expressed as percentage cells positive for each epitope. Increasing colour intensity
indicates an increasing percentage of cells positive. Epitopes in common or enriched in kCFU-F or cCFU-F are shown in expanded
lists alongside heat map. B) Graphical representative of CD profiling for all epitopes where >20% of any cell populations was positive.
Values are an average of 2 replicates with the same cell line.
63Comparisons between MSC-like populationsexpression has been reported in mesangial cells, endothelial
cells and podocytes of the kidney, where its expression in-
creases in response to glomerular injury. It has also
been shown to mark a population of papillary interstitial
cells (Oliver et al., 2004) whose distribution within the kid-
ney shifts from the medulla to the cortex in response to
acute renal ischaemia (Patschan et al., 2007). This may
imply an organ-specific role for these cells in normal tissue
turnover.
For cCFU-F, analysis of differential gene expression im-
plied a possible ‘memory of tissue origin’. The geneencoding the MADS box transcription factor, Mef2c, essen-
tial for deployment of cardiac progenitor cells to the form-
ing heart (Lin et al., 1997), was cCFU-F specific
and expressed 6.6-fold and 66 fold over kCFU-F and
bmMSC levels, respectively. An enhancer responsible
for cardiac Mef2c expression is regulated by the LIM home-
odomain factor ISL1, which is often used to define
cardiac progenitor cells in the embryo and adult
(Dodou et al., 2004). Whilst Isl1 fell just short of
the criteria for tissue-specificity, it was nonetheless
expressed 45-fold and 33-fold above the low levels
Figure 3 Correlation of gene expression profile between bmMSC, cCFU-F and kCFU-F populations. A) Pair-wise correlation of gene
expression profiles (medium-high expression genes only). B) Gene expression heat map of 327 mouse orthologs to defined Plurinet
genes in bmMSC, cCFU-F and kCFU-F. Colour key shown in upper left corner (Log2). C) Representation of the spatial location of Plurinet
gene-encoded proteins expressed in all three MSC-like populations. Only the genes that had expression above background fluorescence
are shown in the network. Level of expression for listed genes is as for panel B. Grey indicates a genewithin the networkwhose expression
was not detected in any population at a level above background.
64 R.A. Pelekanos et al.seen in kidney and bmMSC, respectively. T-box genes
also play a major role in heart development, and
Tbx4 was identified here as cCFU-F-specific. Whilst
not itself expressed in the developing heart, Tbx4 is a para-
logue of Tbx5, which participates in the core cardiac tran-
scription factor gene network and is mutated in Holt–Oram
(hand/heart) syndrome in humans (Basson et al., 1997).
Tbx4 induces the fibroblast growth factor 10 gene
(Fgf10) in limb patterning (Naiche and Papaioannou,
2007) and Fgf10 was also cCFU-F-specific. Other genes in-
volved in transcription, cell shape, migration, growth
and differentiation (Barx1, Ednrb, Gpr88, Ramp3, Gas7,
Mapk13, Mmp3, Sema3F/5F), were also enriched in
cCFU-F, perhaps identifying unique functions or adapta-
tions of cCFU-F.The bmMSC population showed strong enrichment for
Meox1 (10-fold up-regulated in bmMSC), a transcription
factor associated with formation of somites and
maintenance of axial skeleton formation (Mankoo et al.,
2003; Skuntz et al., 2009). This may reflect ‘memory of the
tissue of origin’ or represent the presence of a subpopulation
of more primitive cells. A striking number of immune-related
genes were also found to be either specific to, or enriched
in, bmMSC (Supplementary Table 7). Whilst many of these
appear to be involved in innate immunity (Oas1g, Oasl2,
Ccl9, Cxcl10, Granzyme D/E and Dhx58), they are not
known to influence T-cell proliferation in the assay used
here. Whilst the up-regulation of these genes implies an
active stress response pathway, or even the initiation of a
viral response, other genes indicative of such a response,
Table 1 Gene family/pathways in common between the
three MSC-like populations based upon microarray expres-
sion profiling.
Pathway Predicted expressed proteins
Immunity
associated
proteins
CD1d1, CD binding protein, CD3 epsilon
associated protein, CD8b, CD24, CD80,
CD81, CD99, IL-1 receptor type 1
(CD121a), IL-3 receptor a (CD123),
CD124, CXCL12 receptor (CD184),
CD201, CD276, IL-1, ILf2, IL6st
Cell adhesion CD44, CD29, integrin alpha 5 chain,
CD106, CD51(vitronectin receptor),
integrin α11, integrin alpha FG-GAP
repeat containing 2, integrin αFG-GAP
repeat containing 3, integrin β1 binding
protein 1, integrin β 5, and integrin β-
like 1
BMP pathway Bmp1, Bmper, Bmpr1A, Bmpr1B
CXC chemokines Ccxc1, Cxcl12 (SDF-1), Cx3cl1
(fractalkine), Ccl2, Ccl7 and Ccl25
Homeobox
transcription
factors
HoxA2, HoxA4, HoxA5, HoxA7, HoxB2,
HoxB4, HoxB5, HoxB6, HoxB7
CD epitope
encoding genes
Tetraspanin (CD9), CD14, CD24,
thrombospondin receptor (CD47),
CD49e, CD51, CD59a, CD63, transferrin
receptor (CD71), CD80, CD81, CD82,
Fas receptor (CD95), CD97, CD109, TNF
receptor (CD120), CD124, PGFRα
(CD140a), PGFRβ (CD140b), Mcam
(CD146) CD151, CD164, CD184, CD201,
CD221 IGF-1 receptor (CD221), endo-
sialin (CD248; CD146L).
Metalloproteinases Mmp2, Mmp14, Mmp23, Mmp24
TIMPS Timp1, Timp2, Timp3
65Comparisons between MSC-like populationssuch as MHC class I (H2) and IFNα/γ, were not more highly
expressed in bmMSC.
Dissecting functional differences between
MSC-like populations at the level of protein
Whilst immunophenotypically similar at the level of the
percentage of the population positive for a given epitope, we
investigated whether the observed functional variability
between populations resulted from differences in the
prevalence of individual cell surface epitopes. This was
possible because the immunophenotyping was performed
using PE conjugated antibodies (one PE fluorophore per
antibody), enabling an estimation of relative epitope density
by comparing mean fluorescence intensity between
populations. Overall this analysis highlighted a reduction in
epitope density on the cCFU-F population, a population that
showed little immunosuppressive activity and potentially
reduced multipotency. For 25/81 antibodies, mean intensity
was >20 fold above background in at least one population
(Figure 5A), however this included only 5 antibodies present
on >20% of the cells in those populations. Conversely, of thesix epitopes for which >50% of cells in all population were
positive, three antigens in particular showed considerable
variability in epitope density (CD49e, CD81 and Sca1)
(Figure 5B). kCFU-F showed a lower receptor density of Sca1
compared to bmMSC. cCFU-F showed a generalised reduction
in epitope density for all epitopes apart from CD24 and
CD90.2. In the case of CD24, cCFU-F showed both the highest
percentage (95.35% Figure 2B) and epitope density (11.8 fold
compared to 6.2 fold for bmMSC and 4.7 fold for kCFU-F,
Supplementary Table 2) of all three populations whereas for
CD90.2, whilst only 1.1% of cCFU-F cells were positive
(Figure 2B), they showed the highest mean relative
fluorescence intensity compared to bmMSC and kCFU-F
(Figure 5A). A number of minor subpopulations existed within
which the cells displayed tissue-specific enrichment for
epitope density (Supplementary Tables 2, 3). kCFU-F showed a
very small subpopulation (1.55%) of cells differentially positive
for the chemokine receptor CXCR4 (CD184) (42.5 fold) and
another small subpopulation (1%) differentially positive for
CD41 (Integrin alpha-IIb) (70.8 fold) with respect to bmMSC or
cCFU-F (Supplementary Tables 2, 3).Correlations between gene expression and
immunophenotyping
Whilst there is no guarantee of a direct correlation
between mRNA levels and protein, as not all mRNA is present
at the translational machinery and different cell surface
proteins show different rates of delivery to and recycling
from the plasma membrane, this study did provide a unique
opportunity to directly compare gene expression data with
immunophenotyping. This provided several challenges. Not
all CD epitope-encoding genes were represented on the
microarray. The amount of protein present will depend
upon both the number of cells carrying the protein and
how many copies are present per cell (combination of
percentage positive and relative epitope density). Finally,
some microarray oligonucleotides match alternate
transcripts or map to multiple sites in the genome. To
overcome this, we examined the relative fluorescence for
all oligos representing genes that encoded CD epitopes pre-
sent on >40% of any given population. In this way, we were
able to confirm the expression of 11/13 of these
epitopes (Figure 5C, Supplementary Table 8) with the
remaining falling below the Illumina detection limit. Despite
the overall dimness of the cCFU-F for most epitopes, those
that were present on >40% of cCFU-F showed levels of
gene expression comparable to both bm-MSC and kCFU-F,
suggesting that cCFU-F either showed greater recycling of
epitopes from the cell surface, reduced translation or a
reduction in delivery to the plasma membrane.Discussion
It has previously been shown, based on cell surface immuno-
phenotype and mesodermal differentiation capacity, that
MSC-like cells reside in many postnatal organs in mice (da
Silva Meirelles et al., 2006). Our findings support the notion
that MSC-like populations from diverse organs, isolated
based on a capacity to form CFU-F, share morphological
Figure 4 Differential function and gene expression profile of bmMSC, cCFU-F and kCFU-F. A) Mixed lymphocyte reaction assay of in vitro
immune suppression of T-cell alloreactivity. The ability of each of the threeMSC-like populations to suppress proliferation of T-cells activated
in response to BALB/c [H-2d] stimulator cells. R+S=baseline proliferation (
3
H-thymidine uptake) of activated T-cells in the presence of
stimulator cells. 3×103 or 3×104 cells of each MSC-like population were co-cultured with responders and stimulators. Error bars represent
standard error of the mean, n=3 to 5. Statistics calculated using one way analysis of variance with post hoc Dunnett's test (comparing all
samples to controls). ***=P>0.001, NS = not significantly different. B) Heat map representing the relative expression of 6533 genes
differentially expressed between the three MSC-like populations. Blue — reduced relative expression, red — elevated relative expression.
C) Venn diagram of differentially expressed genes from B). Venn diagram showing numbers of genes statistically differentially expressed
by fold change. D) Representation of the most differentially up-regulated genes present in each of the three MSC-like populations. E) Repre-
sentation of the most differentially down-regulated genes present in each of the three MSC-like populations.
66 R.A. Pelekanos et al.and molecular characteristics as well as multipotency in
common with archetypal bmMSC (Caplan, 1991). Our results
show high congruence in gene expression, mesodermal
potential and immunophenotype. However, embedded in
the detectable differences were expression patterns that
support the hypothesis that tissue-specific MSC populationsare distinct and retain a ‘memory of tissue origin’ reflective
of their unique ontogeny and functional roles.
This is not the first report describing MSC-like populations
from adult organs. Several groups have previously compared
the transcriptional profiles of MSC populations from bone
marrow, amniotic fluid, amniotic membrane and umbilical
Table 2 Five most population-specific gene transcripts for
each of the three populations examined. Genes showing
the greatest enrichment of expression in comparison with
both other populations (enriched genes) were defined as
populations specific if their relative expression was >5
fold higher than the remaining populations, both of which
showed expression of b200RFU (relative fluorescence
units) for the same gene.
Bone marrow MSC specific genes
Gene name (symbol) bmMSC
Raw RFU
cCFU-F
Raw
RFU
kCFU-F
Raw
RFU
Ubiquitin specific peptidase
18 (USP18)
937.12 34.63 39.11
DEXH (Asp-Glu-X-His) box
polypeptide 58 (DHX58)
742.94 42.40 30.41
2′-5′ oligoadenylate
synthetase-like 2 (OASL2)
2471.00 95.86 163.54
Radical S-adenosyl
methionine domain
containing 2 (RSAD2)
852.07 64.12 33.6
Kininogen 2 (Kng2) 1393.55 161.86 155.10
Cardiac cCFU-F specific genes
Gene name (symbol) cCFU-F
Raw RFU
kCFU-F
Raw
RFU
bmMSC
Raw
RFU
Serine (or cysteine)
peptidase inhibitor, clade
A, member 3N (Serpina3n)
11,937.01 12.13 23.66
G-protein coupled receptor
88 (Gpr88)
2710.62 13.29 9.26
Fibroblast growth factor 10
(Fgf10)
1204.88 8.85 11.01
LOC100046120 (similar to
clusterin)
1602.12 11.60 15.18
SLIT and NTRK-like family,
member 5 (Slitrk5)
1819.02 19.77 14.71
Kidney kCFU-F specific genes
Gene name (symbol) kCFU-F
Raw RFU
bmMSC
Raw
RFU
cCFU-F
Raw
RFU
Natriuretic peptide precursor
type B (NPPB)
1132.44 38.67 105.62
LOC100044395 (similar to
RNA binding protein gene
with multiple splicing)
831.74 99.50 63.39
Sciellin (SCEL) 559.75 8.54 66.58
Williams–Beuren syndrome
chromosome region 17
homolog (human)
(WBSCR17)
616.02 73.79 71.70
LOC233466 942.52 179.03 93.15
67Comparisons between MSC-like populationscord blood and compared these to foetal organs, including
developing heart and kidney (Tsai et al., 2007; Menicanin
et al., 2009). As we observed in our studies, such studies
reported Ctgf, CD44, and S100 genes encoding calcium
binding proteins (S100a6 in their study and S100a11 in
ours), serpin peptidase inhibitor genes (Serpine1 versus
Serpinh1 and Serpinf1) and annexins (Anxa1 versus Anxa2)
as some of the most highly expressed genes common to all
sources of MSC. However, other genes previously linked to
MSC were only selectively over-expressed in specific
populations in this study. For example, kCFU-F showed
differential over-expression of Hoxb6 and Anxa1 whereas
cCFU-F showed differential over-expression of Agtr1b.
MSC are reported to be able to home to distant sites of
damage and participate in tissue repair and regeneration.
This occurs in response to adhesion molecules, cytokines
and chemokines, presumably via a mechanism not dissim-
ilar to that required to initiate leukocyte rolling and dia-
pedesis (Kollar et al., 2009). Our immunophenotyping
analysis showed significant expression of CD29 (integrin
α1), CD49e (integrin α5), CD51 (integrin αV) and CD44,
all of which are likely to play a role in cell–cell adhesion
during active homing. Of note, CD61 (integrin α3) was
only detected on bmMSC and kCFU-F. The expression
data revealed marked expression of Mmp2, Mmp13 and
Mmp24 and their inhibitors Timp1, Timp2 and Timp3 in
all three cell types. The balance between MMP and TIMP
is crucial in allowing MSC to migrate through basement
membrane and endothelium to reach a distant sight of in-
jury. It has been recently reported that Mmp/Timp ex-
pression by MSC can be mediated by inflammatory
cytokines. Such compounds may also regulate the mobili-
sation of these populations from perivascular locations in
vivo when required for localised tissue repair (Tondreau
et al., 2009; Ries et al., 2007).
Many immunity-associated genes previously linked to
MSCs were also expressed by all 3 cell populations,
particularly by bmMSC. A comparison of the functional
capacity of each population to influence lymphocytic
proliferation suggested significant differences between
the three sources of cells, with cCFU-F showing little activi-
ty. This has also been observed in a previous study of MSC-
derived populations from foetal heart (Jiang et al., 2006),
although the converse has also been reported
(Hoogduijn et al., 2007). We re-examined the cell
surface immunophenotype of these three populations in
order to identify an underlying mechanism for such function-
al variability. All three populations showed high percentages
of cells positive for CD81, the relative mean intensity of this
epitope on cCFU-F was dramatically lower than in either of
the other populations. CD81 (TAPA-1) is a member of the
transmembrane 4 superfamily whose loss has been associat-
ed with enhanced T-cell proliferation (Miyazaki et al., 1997).
It has been proposed that MSCs mediate their humoral prop-
erties via the secretion of membrane-bound exosomes that
contain a variety of chemokines and have been reported to
contain CD81 (Lai et al., 2010). The delivery of such exo-
somes can reduce infarct size in animal models (Lai et al.,
2010), suggesting a potential role for CD81 in immunosup-
pression. Hence, reduced CD81 may at least in part explain
the reduced immunosuppressive capacity of the cCFU-F
population.
Figure 5 Differential epitope density between bmMSC, cCFU-F and kCFU-F populations and correlations between gene expression
and immunophenotype. A) Graph of fold change in fluorescence intensity (representing relative epitope density) for all epitopes
where at least one population displayed a fold change of >20. B) Graph of fold change in fluorescence intensity for all epitopes
detected on >50% of all three populations. C) Graph indicating the level of gene expression (mean fluorescence intensity) for all
genes encoding CD epitopes detected as present on >40% of cells in any given population. Epitope names are listed rather than the
gene symbol of the encoding gene. Expression of CD201 and CD61 showed an Illumina detection score >0 (not expressed above back-
ground). Gene expression for CD24 was not used as it mapped to more than one location in the genome. Gene expression could not
distinguish between CD90 and CD90.2 hence the intensity displayed is for an oligonucleotide mapping to Thy1, which encodes both
protein isoforms. Data is presented for two Illumina probes representing CD71.
68 R.A. Pelekanos et al.Several studies (Riekstina et al., 2009; Greco et al., 2007;
Barraud et al., 2007; Lengner et al., 2007) have reported the
expression of embryonic stem (ES) cell markers on MSC derived
from bone marrow, adipose, dermal and heart. Knockdown of
Oct4 in MSCs removes them from the cell cycle, as may be the
role for this protein in ES cells. However, not all studies showOct4 expression in MSC and our data suggests no/negligible
expression of this gene. However, we did observe expression
of a large number of Plurinet genes in these MSC populations.
This may indicate a closer alignment to the ‘attractor state’ of
pluri/multipotency than other adult cell populations. Indeed
MSCs from a variety of sources aremore readily reprogrammed
69Comparisons between MSC-like populationsto a pluripotent state than fibroblasts (Yan et al., 2009; Cai et
al., 2010).The proposed association between organ-specific MSC
populations and the pericytic/perivascular compartment
agrees with literature from over 50 years ago addressing the
potency and plasticity of pericytes and their related
lineages (Tilton, 1991). MSCs and pericytes likely share a
common phylogenetic and possibly ontological relationship
being descendants of distinct vascular beds both during
embryo development but also in the adult (Yamashita et al.,
2000), and in the vasculature of tumours (Bexell et al.,
2009). It has been suggested that within the perivascular
environment, a continuum exists between fibroblasts, myofi-
broblasts and vascular smooth muscle cells and that pericytes
and MSC-like populations are closely related and located
adjacent to the vascular endothelium throughout the organs
of the body. In humans, both MSC and pericytes express
CD146, CD140b, CD271 and NG2 suggesting considerable com-
monality between these cell types (Crisan et al., 2008; da Silva
Meirelles et al., 2008; Covas et al., 2008; Sundberg et al.,
2002; Brachvogel et al., 2005). In support of this, we found
gene and/or protein expression of CD146, CD140b, αSMA,
Cspg4/NG2, CD24, Annexin A5, and Desmin in each of our 3
MSC-like populations. The relative level of each marker did
vary, potentially indicating differences in the cell of origin or
position along a lineage continuumof each population, the lat-
ter again potentially being affected by population heteroge-
neity. Analysis of the most compartment-specific genes for
each population particularly supported this hypothesis for
the kCFU-F with enriched expression of Myh11, Mylk, Mcam
(CD146), Efnb2, Edn1, Angpt2 and Vegfc (Supplementary
Table 7C), all of which are associatedwith vascular, lymphatic
or perivascular smooth muscle development. In addition, both
kCFU-F and cCFU-F differentially expressed Crim1, a trans-
membrane regulator of VEGF activity that is known to be
expressed in the perivascular musculature of large arteries
(Pennisi et al., 2007). The stronger link with this ontogeny
and MSC-like fractions isolated from solid organs may be of
significance.
One of the major challenges to the application of MSCs to
organ regeneration and repair in vivo has been cell delivery.
Whilst it has been shown in some studies that MSCs delivered
into the circulation can home to sites of damage, including
sites of ischemic injury in the kidney, the mechanism of
migration is still unclear and there is substantial loss of cells
delivered via this approach (Kollar et al., 2009). To fulfil the
promise of MSC-mediated tissue repair, it may therefore
prove necessary to stimulate the endogenous organ-specific
MSC populations. Our data on the patterns of differential
gene expression between populations provide supporting
evidence for a ‘memory of tissue origin’, highlighting a key
gap in our understanding of CFU-F/MSC biology and the
potential of these cells for tissue repair. Most notable here
was the link between cCFU-F and key developmental
transcriptional networks, including Mef2c and Isl1. Such
tissue-specific signatures may be derivative of the stem cell
or more differentiated components of the colonies. These
may be related in evolutionary or ontological origin and
share a common set of functions, yet nonetheless possess
differentiative potential and/or cellular functions attuned to
their specific roles in the tissue of origin. The other
explanation for such differential gene expression in specificMSC populations would be contamination of the cultures with
organ-specific cell types. The derivation of these MSC
populations from CFU-F, followed by passaging, would make
it unlikely that such residual heterogeneity is the primary
cause of differential gene expression unless these
‘contaminating’ subpopulations were able to proliferate with
a similar phenotype to MSCs. The functional pertinence of
such tissue-specific phenotypes will require additional
functional investigation, but may be critical to conferring
organ-specific regenerative capacities on organ-specific
populations.
In conclusion, this study has expanded our understanding
of the commonalities in genotype, phenotype and function
of murine MSC-like cells of distinct tissue origin. This has
served to further reinforce the concept of a common
perivascular continuum and the retention of organ-specific
roles. Further functional understanding of both the similari-
ties and differences between such organ-specific popula-
tions will be crucial to the development of future cellular
therapeutic approaches to tissue repair as these results
suggest that finding the best “MSC” for a particular clinical
application will be of paramount importance.Materials and methods
Isolation and ex vivo expansion of MSC-like populations
All procedures were approved by the University of Queensland
or the St. Vincent's Hospital/Garvan Institute Animal Ethic
Committees. All MSC populations were derived from mice of
the C57BL/6 strain. Bone/bone marrow MSC (bmMSC) were
isolated from crushed bones as described in Supplementary
data. Both cardiac and kidney MSC populations represent
populations able to be cultured as colony forming unit-
fibroblast (CFU-F) cultures (Friedenstein et al., 1974) although
each were isolated based upon specific protocols devised for
heart or kidney respectively, as described in Supplementary
data. Each biological replicate represented an independently
initiated culture. In the case of cCFU-F, a single culture repre-
sented a single heart with each heart able to generate approx-
imately 17,000 CFU-F colonies. In the case of kidney, one
biological replicate represents isolation from a single animal
(two kidneys), which equates to approximately 3–5000
colonies. As bmMSC was isolated from crushed bones and not
simple bone marrow aspirates, a single replicate represented
the pooled crushed bones of 6–8 animals. Due to the capacity
for CD45+ leucocytes to be propagated alongwith bmMSC, cul-
tures once established were FACS sorted to remove CD45+
cells.
All three cell types were cultured in αMEM
(Invitrogen)+20% FCS for up to 14 passages. Microarray ex-
pression profiling and initial immunophenotyping was per-
formed at passage 5 to 10 (kidney P5, heart P7, bm P10).
Initial immunophenotyping were performed with Sca1,
CD11b, CD29, CD31, CD34, CD44, CD45, CD90.2 and CD117
to establish that they displayed an MSC-like phenotype (Sup-
plementary Figure S1). Subsequent characterization includ-
ed morphological analysis and mesodermal differentiation
assays (Figure 1), performed as described in Supplementary
data.
70 R.A. Pelekanos et al.CD antibody array immunophenotyping
A total of 81 R-Phycoerythrin (PE)-conjugated CD antibodies
were used to examine the immunophenotype of each cell
type. A list of all antibodies used and the protein epitopes
they recognise can be found in Supplementary Table 1. Anti-
bodies were sourced from BD Biosciences and eBioscience.
bmMSC, cCFU-F and kCFU-F were cultured until 70–80% con-
fluent and dissociated from flasks with TrypLE Select (Invitro-
gen), washed with PBS and 5×106 cells were resuspended in
PBS+2% BSA. 5×104 cells were transferred to each well in a
V-bottom 96 well plate and incubated with a 1:100 dilution
of anti-mouse PE-conjugated antibodies. Plates were incubat-
ed on ice for 30 min, centrifuged at 1000 rpm, 5 min, 4 °C,
washed in PBS+1% BSA, fixed in 4% PFA, 15 min on ice before
being washed and resuspended in PBS. Samples were analysed
using BD Bioscience LSRII with microplate reader attachment.
Percentage positive cells (gating relative to unstained nega-
tive control) and mean fluorescence intensity data were cal-
culated using BD FACSDiva software (v 6.1.2). Histogram
overlays of representative results were created using Walter
and Eliza Analysis Software: Eclectic and Lucid (WEASEL,
V2.7.4, Walter and Eliza Hall Institute for Medical Research,
Melbourne, Australia). Tree graphs were created in R software
(v 2.6.2; http://www.r-project.org/) (Smyth, 2005). Initial
experiments using the Violet Viability kit (Invitrogen) were
used to define a region encompassing viable cells on Forward
Scatter Area versus Side Scatter Area dotplot. This was applied
to subsequent analysis where the dye was not used (data not
shown). Positive populations were delineated based upon
gating to exclude non-stained internal negative controls
included in each series of biological replicates (two non-
stained control per dataset). The same gate was applied to
all epitopes analysed in each replicate. The percentage of
cells positive represents the percentage of the counts present
within the positive gate. Mean fluorescence intensity
indicates ce:hsp sp="0.25"/>the mean fluorescence for all
cells within the positive cell gate. The average of these values
for each cell type is tabulated in Supplementary Table 3.
Relative intensity for different epitopes (equivalent to epi-
tope density) within a given biological replicate was
calculated by normalising mean fluorescence intensity back
to the mean fluorescence intensity of the unstained negative
control samples, arbitrarily set at 1.0. This was expressed as
fold change relative to no stain (see Supplementary Table 2).
A direct comparison between immunophenotypic data obtained
using the protocol adopted in the screen with the conventional
FACs performed in the initial immunophenotyping is presented
in Supplementary Figure S5.Microarray sample preparation and data analysis
Detailed microarray sample preparation and analysis methods
can be found in the Supplementary data. Briefly, biological rep-
licates included cells cultured to 65–80% confluence in 4 sepa-
rate flasks concurrently for all three cell types. The same
batch of αMEM and FCS was used for all cells and handling was
carried out on all cells simultaneously tominimise transcription-
al noise. Biotin-labelled cRNA was hybridised to mouse WG6 v2
array (Illumina Inc, San Diego, CA) at 55 °C for 18 h, followed
by labelling with streptavidin-Cy3 (GE Healthcare). Arrayswere scanned with the BeadStation 500 System and raw probe
expression values were extracted using BeadStudio v3 software
(Illumina). The complete microarray data can be found in the
publicly accessible GEO database (GSE31738; GSM787845 to
GSM787856). Further details of data analyses are described in
Supplementary data. In brief, raw probe expression values
were imported in R software (version 2.6.2) (Smyth, 2005),
background corrected and quantile normalised using the Lumi
package (Du et al., 2008). Using the LIMMA package (Smyth,
2005), an Empirical Bayes Analysis was run to determine the
genes with significant differential expression between each of
the three cell types. This analysis included a multiple testing
correction to reduce false positives (Smyth, 2004). For each
pair-wise comparison genes with a B-score greater than
0 were selected as significant (pb0.005).
In order to measure the similarity between the three cell
types, Pearson correlations of each cell type against each
other were calculated (r2). The correlations were based on
a subset of genes with medium to high expression levels
selected using Illumina's Detection Score (20,662 genes).
Ingenuity Pathway Analysis (Ingenuity Systems Inc., Redwood
City, CA) was performed to categorise the differentially regu-
lated genes.
When comparing gene expression with protein levels of
CD epitopes, all oligonucleotides designated as representing
a given CD epitope encoding gene were mapped back to the
UCSC mouse genome build to check for oligonucleotides that
mapped to multiple locations in the genome (multimap-
pers), alternative isoforms or the wrong locus. Data from ol-
igonucleotides was also excluded from the comparison if the
expression of that oligonucleotide was regarded as below
background as determined by an Illumina detection score
of >0.Mixed leukocyte reaction (MLR) assay
Mixed lymphocyte reaction assays were performed as previ-
ously described (Christensen et al., 2010). bmMSC, cCFU-F
and kCFU-F were plated at 3000 or 30 000 cells per well in a
U-bottom 96 well plate (Greiner, Kremsmünster, Austria) in
αMEM+20% FCS overnight and then irradiated (2000 cGy)
prior to co-culture. Assays were carried out in complete
media (αMEM, 10% FCS, β-mercaptoethanol, HEPES and
P/S/G). Stimulator splenocyte cells from BALB/c mice were
cultured overnight with 100 ng/ml lipopolysaccharide (LPS,
Sigma-Aldrich) in culture media in a humidified 37 °C, 5%
CO2 incubator, then irradiated (2000 cGy) prior to co-culture
(Christensen et al., 2010). Responder T-cells derived from
C57BL/6 mice were purified using a pan T-cell isolation kit
(Miltenyi Biotec, Gladbach, Germany). Stimulator cells
(2×105 cells/well) and responder T-cells (3×105 cells/well)
were co-cultured (complete αMEM) in a humidified 37 °C, 5%
CO2 incubator. Proliferation was assessed by [ 3H]-thymidine
incorporation (1 μcurie/well) (GE Healthcare) after a total of
96 h of culture. Cells were harvested using the TOMTEC 96-
well Mach III Harvester (Perkin-Elmer, Victoria, Australia)
and counts per minute (cpm) measured on a 1450 MICROBETA
TRILUX β-scintillation counter (Perkin-Elmer).Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2011.08.003.
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